{"id":70954,"date":"2026-03-09T11:55:20","date_gmt":"2026-03-09T11:55:20","guid":{"rendered":"https:\/\/indogenmed.org\/?post_type=product&#038;p=70954"},"modified":"2026-06-28T18:33:57","modified_gmt":"2026-06-28T18:33:57","slug":"hemlibra-60mg-injection","status":"publish","type":"product","link":"https:\/\/indogenmed.org\/fr\/product\/hemlibra-60mg-injection\/","title":{"rendered":"Injection d&#8217;Hemlibra 60mg"},"content":{"rendered":"<p>L&#8217;injection d&#8217;Hemlibra 60mg est un m\u00e9dicament r\u00e9volutionnaire con\u00e7u pour le traitement de l&#8217;h\u00e9mophilie A, un trouble h\u00e9morragique g\u00e9n\u00e9tique rare. Son principe actif, l&#8217;emicizumab, est un anticorps monoclonal bisp\u00e9cifique qui imite la fonction d&#8217;un facteur de coagulation manquant (facteur VIII) dans le sang. En reliant le facteur IX activ\u00e9 et le facteur X, l&#8217;emicizumab facilite la conversion de la prothrombine en thrombine, favorisant ainsi la formation de caillots sanguins et r\u00e9duisant la fr\u00e9quence des \u00e9pisodes h\u00e9morragiques. Hemlibra est administr\u00e9 par voie sous-cutan\u00e9e et est g\u00e9n\u00e9ralement utilis\u00e9 pour la prophylaxie de routine (traitement pr\u00e9ventif) chez les patients atteints d&#8217;h\u00e9mophilie A, avec ou sans inhibiteurs du facteur VIII. Il est crucial d&#8217;utiliser Hemlibra exactement comme prescrit par votre professionnel de la sant\u00e9. Ne vous auto-administrez pas et ne modifiez pas la posologie sans consultation m\u00e9dicale. Conservez l&#8217;injection \u00e0 temp\u00e9rature ambiante (20\u00b0C \u00e0 25\u00b0C ou 68\u00b0F \u00e0 77\u00b0F) et prot\u00e9gez-la de la lumi\u00e8re. Ne pas r\u00e9frig\u00e9rer ni congeler.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;injection d&#8217;Hemlibra 60mg est utilis\u00e9e pour pr\u00e9venir les \u00e9pisodes h\u00e9morragiques chez les personnes atteintes d&#8217;h\u00e9mophilie A. Elle est administr\u00e9e par injection sous-cutan\u00e9e, selon les prescriptions de votre m\u00e9decin.<\/p>\n","protected":false},"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[20168],"product_cat":[17264],"product_tag":[20173,20172,15985,15986],"class_list":["post-70954","product","type-product","status-publish","product_brand-roche-products","product_cat-anemia-medicines","product_tag-emicizumab","product_tag-hemlibra","product_tag-injection","product_tag-vial","pa_brand-name-hemlibra","pa_molecule-emicizumab","first","instock","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product\/70954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/comments?post=70954"}],"version-history":[{"count":0,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product\/70954\/revisions"}],"wp:attachment":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/media?parent=70954"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_brand?post=70954"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_cat?post=70954"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_tag?post=70954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}